Analyze awards, watch incumbents and competitors, track new transactions or changes, and use award history to shape recompete and capture strategy.
Award ID | Description | Recipient | Total Value | Awarding Agency | Funding Agency | Set Aside | NAICS | PSC | Award Date | Start Date | End Date | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| ADVANCE THE DEVELOPMENT OF TWO ANTIBIOTICS FOR USE IN THE PEDIATRIC POPULATION FOR THE TREATMENT OF SERIOUS BACTERIAL INFECTIONS WHERE MULTIDRUG-RESISTANT ORGANISMS ARE COMMON, AND 2) DEVELOP ANTIBIOTICS FOR USE IN PUBLIC HEALTH AND BIOTHREAT EMERGEN | MELINTA THERAPEUTICS, LLC | $164,300,757 | OFFICE OF ASSISTANT SECRETARY FOR PREPAREDNESS AND RESPONSE | OFFICE OF ASSISTANT SECRETARY FOR PREPAREDNESS AND RESPONSE | — | 541714Research and Development in Biotechnology (except Nanobiotechnology) | AN44HEALTH R&D SERVICES; HEALTH CARE - OTHER; R&D ADMINISTRATIVE EXPENSES | Jul 6, 2023 | Jul 6, 2023 | Aug 6, 2034 |